adenosine monophosphate has been researched along with Arterial Obstructive Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barchetti, G; Boccardi, E; Cervo, A; Ferrari, F; Pero, G; Piano, M; Quilici, L | 1 |
| Chepurko, E; Covarrubias, R; Cowan, PJ; Dwyer, KM; Gumina, RJ; Huttinger, R; Huttinger, ZM; Novitskaya, T; Reynolds, A; Robson, SC; Stanfill, K; Wheeler, DG | 1 |
| Humphries, RG; van Giezen, JJ | 1 |
| Allison, TB; Holsinger, JW | 1 |
| Capecchi, PL; Chiavetta, M; De Lalla, A; Di Perri, T; Laghi Pasini, F; Sensi, S; Sodi, N; Volpi, L | 1 |
| Driscoll, EM; Gonzales, ML; Huang, J; Lucchesi, BR; Park, AM | 1 |
1 review(s) available for adenosine monophosphate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Administration, Oral; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Rabbits; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor | 2005 |
1 trial(s) available for adenosine monophosphate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Increase in plasma levels of adenosine and adenine nucleotides after intravenous infusion of buflomedil in humans.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Analysis of Variance; Arterial Occlusive Diseases; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrrolidines; Vasodilator Agents | 1995 |
4 other study(ies) available for adenosine monophosphate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Use of Cangrelor in Cervical and Intracranial Stenting for the Treatment of Acute Ischemic Stroke: A "Real Life" Single-Center Experience.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery, Internal; Cerebral Hemorrhage; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thrombectomy; Treatment Outcome | 2020 |
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Arterial Occlusive Diseases; Blood Coagulation; Bone Marrow Transplantation; Chlorides; Disease Models, Animal; Endothelial Cells; Ferric Compounds; Genetic Predisposition to Disease; HEK293 Cells; Humans; Hydrolysis; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Monocytes; Phenotype; Platelet Activation; Thrombosis; Time Factors; Transfection | 2016 |
Myocardial metabolism and regional myocardial blood flow in the canine left ventricle following twenty minutes of circumflex artery occlusion and reperfusion.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Dogs; Endocardium; Glucose-6-Phosphate; Glucosephosphates; Heart Ventricles; Hyperemia; Myocardium; Phosphocreatine | 1983 |
Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Arterial Occlusive Diseases; Bleeding Time; Blood Flow Velocity; Blood Platelets; Carotid Arteries; Carotid Artery Thrombosis; Disease Models, Animal; Dogs; Female; Hemodynamics; Injections, Intravenous; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Tunica Intima | 2000 |